# Levothyroxine Sodium

NDC: 0615-8599
Generic name: Levothyroxine Sodium
Labeler / Manufacturer: NCS HealthCare of KY, LLC dba Vangard Labs
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20031201

FDA application: NDA021210

## Active ingredients

- LEVOTHYROXINE SODIUM: .1 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0615-8599"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0615-8599
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=abe173cc-1579-43a5-b12d-a31958d0a539